Patents by Inventor Rene Gaudreault

Rene Gaudreault has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20070249622
    Abstract: This invention relates to the use of nicotine receptor agonists or analogues or derivatives thereof for treating inflammatory pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases.
    Type: Application
    Filed: June 21, 2007
    Publication date: October 25, 2007
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene Gaudreault, Phillippe Labrie
  • Publication number: 20050250853
    Abstract: Disclosed herein are ?-tubulin inhibitors of formula I, prodrugs thereof and therapeutically acceptable salts thereof, wherein R is selected from the group consisting of: t-butyl, i-propyl and sec-butyl and their use as anti-cancer cell proliferation agents.
    Type: Application
    Filed: March 7, 2005
    Publication date: November 10, 2005
    Inventors: Rene Gaudreault, Jean Legault
  • Publication number: 20050130990
    Abstract: This invention relates to the use of nicotine receptor agonists or analogues or derivatives thereof for treating inflammatory pulmonary diseases. Such agonists have fewer side effects than other anti-inflammatory drugs, such as steroids. Moreover, these agonists can be used alone or in combination with other anti-inflammatory drugs to alleviate pulmonary diseases.
    Type: Application
    Filed: July 15, 2004
    Publication date: June 16, 2005
    Applicant: UNIVERSITE LAVAL
    Inventors: Yvon Cormier, Evelyne Israel-Assayag, Marie-Renee Blanchet, Rene Gaudreault, Philippe Labrie